CervoMed
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $3,288 | $2,347 | $2,490 |
Gross Profit | 3,288 | -467 | -364 |
EBITDA | -2,995 | -2,594 | -2,480 |
EBIT | -2,995 | -2,594 | -1,680 |
Net Income | -2,316 | -2,514 | -2,362 |
Net Change In Cash | 3,288 | 2,347 | 2,490 |
Free Cash Flow | -2,201 | -1,423 | -2,538 |
Cash | 10,009 | 6,369 | 7,792 |
Basic Shares | 8,702 | 6,170 | 5,674 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7,144 | $0 | $0 | $0 |
Gross Profit | -1,293 | -1,336 | -93 | -103 |
EBITDA | -2,171 | -3,475 | -24,446 | -15,757 |
EBIT | -2,171 | -15,972 | -24,539 | -15,860 |
Net Income | -2,171 | -15,591 | -24,095 | -14,185 |
Net Change In Cash | 7,144 | 0 | 0 | 0 |
Free Cash Flow | -7,449 | -2,572 | -14,501 | -13,552 |
Cash | 7,792 | 4,093 | 37,313 | 18,515 |
Basic Shares | 2,661 | 518 | 1,301 | 717 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.54 |
2024-06-30 | -$0.27 |
2024-03-31 | -$0.41 |
2023-12-31 | -$0.38 |
